MRI tracking of transplanted iron-labeled mesenchymal stromal cells in an immune-compromised mouse model of critical limb ischemia

NMR in Biomedicine

Volumn 26, Issue 4, 2013, Pages 458-467

  Noad, Jennifer ^a,b   Gonzalez Lara, Laura E ^a,b   Broughton, Heather C ^a   Mcfadden, Catherine ^a   Chen, Yuhua ^a   Hess, David A ^a,b   Foster, Paula J ^a,b  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Cell tracking; Femoral artery ligation; Iron; Mesenchymal stromal cell (MSC); Mice; MRI

Indexed keywords

CELL TRACKING; CELL TRANSPLANTATION; CLINICAL PROBLEMS; FEMORAL ARTERY; MESENCHYMAL STROMAL CELLS; MICE; PERIPHERAL ARTERIAL DISEASE; TRANSPLANTED CELLS;

BLOOD VESSELS; FLOWCHARTING; IRON; IRON OXIDES; MACROPHAGES; MAGNETIC RESONANCE IMAGING; MAMMALS;

CELL CULTURE;

ENDOGLIN; INTERLEUKIN 2 RECEPTOR GAMMA; IRON; RHODAMINE B; THY 1 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY LIGATION; ARTICLE; B LYMPHOCYTE; BYSTANDER EFFECT; CELL LABELING; CELL TRACKING; CELL TRANSPLANTATION; CELL VIABILITY; CONTROLLED STUDY; CRITICAL LIMB ISCHEMIA; FEMORAL ARTERY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HISTOPATHOLOGY; IN VIVO STUDY; MALE; MESENCHYMAL STROMA CELL; MICROSCOPY; MOUSE; NATURAL KILLER CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCID MOUSE; T LYMPHOCYTE; ANIMAL; C57BL MOUSE; CELL SURVIVAL; CYTOLOGY; DISEASE MODEL; IMMUNOCOMPROMISED PATIENT; INTRAMUSCULAR DRUG ADMINISTRATION; ISCHEMIA; LIMB; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; NONOBESE DIABETIC MOUSE; PATHOLOGY; STAINING; VASCULARIZATION;

MUS;

ANIMALS; CELL SURVIVAL; CELL TRACKING; DISEASE MODELS, ANIMAL; EXTREMITIES; FLOW CYTOMETRY; IMMUNOCOMPROMISED HOST; INJECTIONS, INTRAMUSCULAR; INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT; IRON; ISCHEMIA; MAGNETIC RESONANCE IMAGING; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, SCID; STAINING AND LABELING;

EID: 84875050554     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.2884     Document Type: Article

References (47)

1. Lawall H, Bramlage P, Amann B. Stem cell and progenitor cell therapy in peripheral artery disease. A critical appraisal. Thromb. Haemost. 2010; 103: 696-709.
2. Koc ON, Gerson SL, Cooper BW, Dyhouse SM, Haynesworth SE, Caplan AI, Lazarus HM. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J. Clin. Oncol. 2000; 18: 307-316.
3. Karussis D, Vaknin-Dembinsky A. Hematopoietic stem cell transplantation in multiple sclerosis: a review of the clinical experience and a report of an international meeting. Expert Rev. Clin. Immunol. 2010; 6: 347-352.
4. Passweg J, Tyndall A. Autologous stem cell transplantation in autoimmune diseases. Semin. Hematol. 2007; 44: 278-285.
5. Wright KT, El Masri W, Osman A, Chowdhury J, Johnson WE. Concise review: bone marrow for the treatment of spinal cord injury: mechanisms and clinical applications. Stem Cells 2011; 29: 169-178.
6. Tyndall A, Daikeler T. Autologous hematopoietic stem cell transplantation for autoimmune diseases. Acta Haematol. 2005; 114: 239-247.
7. Gogel S, Gubernator M, Minger SL. Progress and prospects: stem cells and neurological diseases. Gene Ther. 2011; 8: 1-6.
8. Urbaniak Hunter K, Yarbrough C, Ciacci J. Stem cells in the treatment of stroke. Adv. Exp. Med. Biol. 2010; 671: 105-116.
9. Fotino C, Ricordi C, Lauriola V, Alejandro R, Pileggi A. Bone marrow-derived stem cell transplantation for the treatment of insulin-dependent diabetes. Rev. Diabet. Stud. 2010; 7: 144-157.
10. Chamberlain G, Fox J, Ashton B, Middleton J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007; 25: 2739-2749.
11. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147.
12. Hematti P. Role of mesenchymal stromal cells in solid organ transplantation. Transplant. Rev. (Orlando) 2008; 22: 262-273.
13. Phinney DG, Prockop DJ. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair - current views. Stem Cells 2007; 25: 2896-2902.
14. Cho HH, Kim YJ, Kim JT, Song JS, Shin KK, Bae YC, Jung JS. The role of chemokines in proangiogenic action induced by human adipose tissue-derived mesenchymal stem cells in the murine model of hindlimb ischemia. Cell. Physiol. Biochem. 2009; 24: 511-518.
15. Hong SJ, Traktuev DO, March KL. Therapeutic potential of adipose-derived stem cells in vascular growth and tissue repair. Curr. Opin. Organ Transplant. 2010; 15: 86-91.
16. Kinnaird T, Stabile E, Burnett MS, Shou M, Lee CW, Barr S, Fuchs S, Epstein SE. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 2004; 109: 1543-1549.
17. Limbourg A, Korff T, Napp LC, Schaper W, Drexler H, Limbourg FP. Evaluation of postnatal arteriogenesis and angiogenesis in a mouse model of hind-limb ischemia. Nat. Protoc. 2009; 4: 1737-1746.
18. Schwarz TM, Leicht SF, Radic T, Rodriguez-Araboalaza I, Hermann PC, Berger F, Saif J, Bocker W, Ellwart JW, Aicher A, Heeschen C. Vascular incorporation of endothelial colony-forming cells is essential for functional recovery of murine ischemic tissue following cell therapy. Arterioscler. Thromb. Vasc. Biol. 2012; 32: e13-e21.
19. Laurila JP, Laatikainen L, Castellone MD, Trivedi P, Heikkila J, Hinkkanen A, Hematti P, Laukkanen MO. Human embryonic stem cell-derived mesenchymal stromal cell transplantation in a rat hind limb injury model. Cytotherapy 2009; 11: 726-737.
20. Bulte JW, Duncan ID, Frank JA. In vivo magnetic resonance tracking of magnetically labeled cells after transplantation. J. Cereb. Blood Flow Metab. 2002; 22: 899-907.
21. Bulte JW, Kraitchman DL. Monitoring cell therapy using iron oxide MR contrast agents. Curr. Pharm. Biotechnol. 2004; 5: 567-584.
22. Bulte JW, Kraitchman DL. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed. 2004; 17: 484-499.
23. McFadden C, Mallett CL, Foster PJ. Labeling of multiple cell lines using a new iron oxide agent for cell tracking by MRI. Contrast Media Mol. Imaging 2011; 6: 514-522.
24. Ribot EJ, Martinez-Santiesteban FM, Simedrea C, Steeg PS, Chambers AF, Rutt BK, Foster PJ. In vivo single scan detection of both iron-labeled cells and breast cancer metastases in the mouse brain using balanced steady-state free precession imaging at 1.5T. J. Magn. Reson. Imaging 2011; 34: 231-238.
25. Rohani R, de Chickera SN, Willert C, Chen Y, Dekaban GA, Foster PJ. In vivo cellular MRI of dendritic cell migration using micrometer-sized iron oxide (MPIO) particles. Mol. Imaging Biol. 2011; 13: 679-694.
26. Arbab AS, Frank JA. Cellular MRI and its role in stem cell therapy. Regen. Med. 2008; 3: 199-215.
27. Modo M, Hoehn M, Bulte JW. Cellular MR imaging. Mol. Imaging 2005; 4: 143-164.
28. Amsalem Y, Mardor Y, Feinberg MS, Landa N, Miller L, Daniels D, Ocherashvilli A, Holbova R, Yosef O, Barbash IM, Leor J. Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium. Circulation 2007; 116: I38-I45.
29. Terrovitis J, Stuber M, Youssef A, Preece S, Leppo M, Kizana E, Schar M, Gerstenblith G, Weiss RG, Marban E, Abraham MR. Magnetic resonance imaging overestimates ferumoxide-labeled stem cell survival after transplantation in the heart. Circulation 2008; 117: 1555-1562.
30. Winter EM, Hogers B, van der Graaf LM, Gittenberger-de Groot AC, Poelmann RE, van der Weerd L. Cell tracking using iron oxide fails to distinguish dead from living transplanted cells in the infarcted heart. Magn. Reson. Med. 2010; 63: 817-821.
31. Gonzalez-Lara LE, Xu X, Hofstetrova K, Pniak A, Chen Y, McFadden CD, Martinez-Santiesteban FM, Rutt BK, Brown A, Foster PJ. The use of cellular magnetic resonance imaging to track the fate of iron-labeled multipotent stromal cells after direct transplantation in a mouse model of spinal cord injury. Mol. Imaging Biol. 2011; 13: 702-11.
32. Berman SC, Galpoththawela C, Gilad AA, Bulte JW, Walczak P. Long-term MR cell tracking of neural stem cells grafted in immunocompetent versus immunodeficient mice reveals distinct differences in contrast between live and dead cells. Magn. Reson. Med. 2011; 65: 564-574.
33. Gianella A, Guerrini U, Tilenni M, Sironi L, Milano G, Nobili E, Vaga S, Capogrossi MC, Tremoli E, Pesce M. Magnetic resonance imaging of human endothelial progenitors reveals opposite effects on vascular and muscle regeneration into ischaemic tissues. Cardiovasc. Res. 2010; 85: 503-513.
34. Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K, Ueyama Y, Koyanagi Y, Sugamura K, Tsuji K, Heike T, Nakahata T. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 2002; 100: 3175-3182.
35. Okabe M, Ikawa M, Kominami K, Nakanishi T, Nishimune Y. 'Green mice' as a source of ubiquitous green cells. FEBS Lett. 1997; 407: 313-319.
36. Pawelczyk E, Arbab AS, Chaudhry A, Balakumaran A, Robey PG, Frank JA. In vitro model of bromodeoxyuridine or iron oxide nanoparticle uptake by activated macrophages from labeled stem cells: implications for cellular therapy. Stem Cells 2008; 26: 1366-1375.
37. Pawelczyk E, Jordan EK, Balakumaran A, Chaudhry A, Gormley N, Smith M, Lewis BK, Childs R, Robey PG, Frank JA. In vivo transfer of intracellular labels from locally implanted bone marrow stromal cells to resident tissue macrophages. PLoS One 2009; 4: e6712.
38. Addicott B, Willman M, Rodriguez J, Padgett K, Han D, Berman D, Hare JM, Kenyon NS. Mesenchymal stem cell labeling and in vitro MR characterization at 1.5T of new SPIO contrast agent: Molday ION Rhodamine-B. Contrast Media Mol. Imaging 2011; 6: 7-18.
39. Jirak D, Kriz J, Strzelecki M, Yang J, Hasilo C, White DJ, Foster PJ. Monitoring the survival of islet transplants by MRI using a novel technique for their automated detection and quantification. MAGMA 2009; 22: 257-265.
40. Derval N, Barandon L, Dufourcq P, Leroux L, Lamaziere JM, Daret D, Couffinhal T, Duplaa C. Epicardial deposition of endothelial progenitor and mesenchymal stem cells in a coated muscle patch after myocardial infarction in a murine model. Eur. J. Cardiothorac. Surg. 2008; 34: 248-254.
41. Iwase T, Nagaya N, Fujii T, Itoh T, Murakami S, Matsumoto T, Kangawa K, Kitamura S. Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia. Cardiovasc. Res. 2005; 66: 543-551.
42. Wang Y, Xu F, Zhang C, Lei D, Tang Y, Xu H, Zhang Z, Lu H, Du X, Yang GY. High MR sensitive fluorescent magnetite nanocluster for stem cell tracking in ischemic mouse brain. Nanomedicine 2011; 7: 1009-1019.
43. Togel F, Yang Y, Zhang P, Hu Z, Westenfelder C. Bioluminescence imaging to monitor the in vivo distribution of administered mesenchymal stem cells in acute kidney injury. Am. J. Physiol. Renal Physiol. 2008; 295: F315-F321.
44. Schlosser S, Dennler C, Schweizer R, Eberli D, Stein JV, Enzmann V, Giovanoli P, Erni D, Plock JA. Paracrine effects of mesenchymal stem cells enhance vascular regeneration in ischemic murine skin. Microvasc. Res. 2012; 83: 267-275.
45. Au P, Tam J, Fukumura D, Jain RK. Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature. Blood 2008; 111: 4551-4558.
46. Shultz LD, Ishikawa F, Greiner DL. Humanized mice in translational biomedical research. Nat. Rev. Immunol. 2007; 7: 118-130.
47. King MA, Covassin L, Brehm MA, Racki W, Pearson T, Leif J, Laning J, Fodor W, Foreman O, Burzenski L, Chase TH, Gott B, Rossini AA, Bortell R, Shultz LD, Greiner DL. Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex. Clin. Exp. Immunol. 2009; 157: 104-118.